Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Healthcare (Basel, Switzerland)|January 20, 2021
Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi ArabiaThamir A Alandijany, Sherif A El-Kafrawy, Abrar A Al-Ghamdi, et al.
Plos Pathogens|September 19, 2022
SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected miceSherif A El-Kafrawy, Abby Odle, Aymn T Abbas, et al.
Journal of Medical Virology|September 6, 2022
A potential association between obesity and reduced effectiveness of COVID-19 vaccine-induced neutralizing humoral immunityArwa A Faizo, Fadi S Qashqari, Sherif A El-Kafrawy, et al.
Acta Tropica|April 6, 2018
Diversity of dengue virus-3 genotype III in Jeddah, Saudi ArabiaAnwar M Hashem, Sayed S Sohrab, Sherif A El-Kafrawy, et al.
Virology Journal|January 17, 2015
Complete genome sequencing and phylogenetic analysis of dengue type 1 virus isolated from Jeddah, Saudi ArabiaEsam I Azhar, Anwar M Hashem, Sherif A El-Kafrawy, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 19, 2021
Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A lightS I Hindawi, S A El-Kafrawy, A M Hassan, et al.
Viruses|February 28, 2023
Hepatitis E Virus (HEV) in Makkah, Saudi Arabia: A Population-Based Seroprevalence StudyMai M El-Daly, Rajaa Al-Raddadi, Amany Alharbi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 20, 2020
Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapiesAlimuddin Zumla, Fu-Sheng Wang, Giuseppe Ippolito, et al.
Journal of Visualized Experiments : Jove|July 14, 2025
COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in JeddahAbrar A Al-Ghamdi, Thamir A Alandijany, Arwa A Faizo, et al.
Pageof 8